Ratings Samsung Life Insurance Co., Ltd.

Equities

A032830

KR7032830002

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
86,100 ^KRW	+2.26%		+5.90%	+24.60%

Mar. 12	Samsung Group Initiates Open Hiring Drive for New Talent Acquisition	MT
Feb. 21	Samsung Life Insurance Rallies on Hopes for Better Shareholder Returns	DJ

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental situation
The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

Strengths

Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Its low valuation, with P/E ratio at 7.78 and 7.15 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company's share price in relation to its net book value makes it look relatively cheap.
This company will be of major interest to investors in search of a high dividend stock.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
SAMSUNG LIFE INSURANCE CO., LTD.	+24.60%	10.97B	A-
AXA	+18.41%	80.39B	B-
METLIFE, INC.	+9.22%	52.03B	B+
AFLAC INCORPORATED	+1.48%	48.06B	B
MANULIFE FINANCIAL CORPORATION	+9.92%	42.17B	B+
GENERALI	+20.86%	37.62B	B
SUN LIFE FINANCIAL INC.	+3.07%	29.99B	B
GREAT-WEST LIFECO INC.	-8.20%	27.31B	B-
PRUDENTIAL PLC	-16.30%	24.85B	A-
CATHAY FINANCIAL HOLDING CO., LTD.	+6.56%	21.75B	A

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes